Jasmine

Drospirenone/Ethinylestradiol, the active ingredient in Jasmine, is a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy and is also indicated for regulation of menstrual cycles, providing reliable birth control for women of reproductive age.

GNH USA supplies Jasmine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to European Union regulatory requirements and manufactured under strict quality controls to ensure consistency and safety for international markets.

Jasmine, a combined oral contraceptive, acts on the hormonal regulation pathway to prevent pregnancy and manage menstrual disorders.

Contraception: provides reliable birth control by preventing ovulation. Menstrual cycle regulation: helps achieve predictable bleeding patterns and reduces cycle‑related symptoms. Hormonal disorder management: may be prescribed under medical supervision to address estrogen‑dependent conditions such as polycystic ovary syndrome.

Jasmine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea or upset stomach. - Breast tenderness or enlargement. - Headache or migraine. - Spotting or breakthrough bleeding. - Weight gain or fluid retention. - Mood changes or irritability.

Serious or Rare Side Effects: - Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism). - Arterial thrombosis (stroke, myocardial infarction). - Severe hypertension or hypertensive crisis. - Liver disorders, including cholestasis. - Gallbladder disease (cholelithiasis, cholecystitis). - Anaphylaxis or severe allergic reaction.

Before prescribing Jasmine, clinicians should consider several safety precautions to minimize risk.

Pregnancy contraindication: must not be used during pregnancy (Category X). Smoking restriction: avoid in women over 35 who smoke more than 15 cigarettes per day. Thromboembolic history: contraindicated in patients with a history of venous or arterial thrombosis. Hypertension: use with caution in patients with uncontrolled high blood pressure. Liver disease: avoid in severe hepatic impairment. Store below 25°C: keep in the original packaging, protect from moisture and heat.

Jasmine can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - CYP3A4 inducers (e.g., rifampin) may reduce contraceptive efficacy. - Anticonvulsants (phenytoin, carbamazepine) can lower hormone levels. - St. John's wort may increase metabolism of the active ingredients.

Moderate Interactions (Monitor Closely): - Antifungals (ketoconazole) may increase plasma concentrations. - Selective serotonin reuptake inhibitors (fluoxetine) may affect hormone metabolism.